In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…

By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…

At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…